![Delta vs. Omicron Variant Symptoms: How New COVID Variant Might Differ From Previous Cases – NBC Chicago Delta vs. Omicron Variant Symptoms: How New COVID Variant Might Differ From Previous Cases – NBC Chicago](https://media.nbcchicago.com/2021/11/tlmd-omicron-variante-shutterstock_2081553577-copy.jpg?quality=85&strip=all)
Delta vs. Omicron Variant Symptoms: How New COVID Variant Might Differ From Previous Cases – NBC Chicago
![SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-00997-x/MediaObjects/41392_2022_997_Fig1_HTML.png)
SARS-CoV-2 Omicron variant: recent progress and future perspectives | Signal Transduction and Targeted Therapy
![Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic? - Ding - 2022 - Immunity, Inflammation and Disease - Wiley Online Library Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic? - Ding - 2022 - Immunity, Inflammation and Disease - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8c88078b-57aa-46c4-a3a4-619d93add0c0/iid3606-fig-0002-m.jpg)
Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic? - Ding - 2022 - Immunity, Inflammation and Disease - Wiley Online Library
![Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The](https://www.thelancet.com/cms/attachment/7eb37bf9-6d97-485f-805e-207b29973336/gr1_lrg.jpg)
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The
![Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England | Nature Communications Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-34244-2/MediaObjects/41467_2022_34244_Fig1_HTML.png)
Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England | Nature Communications
![Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The](https://www.thelancet.com/cms/attachment/8e33f9d1-8d6e-4d59-93c0-3a3d193f7cd0/gr2_lrg.jpg)
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The
![Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study - The Lancet Infectious Diseases Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/0445b350-f6e7-48ae-b3f9-22ef22b1fa6f/gr1.jpg)